These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 39252044
21. Genetic variability and functional implication of HPV16 from cervical intraepithelial neoplasia in Shanghai women. Zhao J, Zhu J, Guo J, Zhu T, Zhong J, Liu M, Ruan Y, Liao S, Li F. J Med Virol; 2020 Mar; 92(3):372-381. PubMed ID: 31670402 [Abstract] [Full Text] [Related]
23. High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia. Persson M, Brismar Wendel S, Ljungblad L, Johansson B, Weiderpass E, Andersson S. Oncol Rep; 2012 Jul; 28(1):346-52. PubMed ID: 22484610 [Abstract] [Full Text] [Related]
24. Genetic variability of human papillomavirus type 18 based on E6, E7 and L1 genes in central China. Li T, Yang Z, Luo P, Yang Y, Lin Z, Mei B. Virol J; 2024 Jul 05; 21(1):152. PubMed ID: 38970084 [Abstract] [Full Text] [Related]
25. [Correlation between high risk type human papillomavirus E6/E7 mRNA and cervical cancer]. Wang XH, Qian YM, Miao L, Le Y, Du J. Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jul 05; 37(7):1003-5. PubMed ID: 27453113 [Abstract] [Full Text] [Related]
27. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia. Sathish N, Abraham P, Peedicayil A, Sridharan G, John S, Chandy G. Mol Diagn; 2004 Jul 05; 8(1):57-64. PubMed ID: 15230643 [Abstract] [Full Text] [Related]
28. Use of hTERT and HPV E6/E7 mRNA RT-qPCR TaqMan assays in combination for diagnosing high-grade cervical lesions and malignant tumors. Wang HY, Park S, Kim S, Lee D, Kim G, Kim Y, Park KH, Lee H. Am J Clin Pathol; 2015 Mar 05; 143(3):344-51. PubMed ID: 25696792 [Abstract] [Full Text] [Related]
29. Design and evaluation of a multi-epitope DNA vaccine against HPV16. Zhu L, Cui X, Yan Z, Tao Y, Shi L, Zhang X, Yao Y, Shi L. Hum Vaccin Immunother; 2024 Dec 31; 20(1):2352908. PubMed ID: 38780076 [Abstract] [Full Text] [Related]
30. Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer. Kaufmann AM, Stern PL, Rankin EM, Sommer H, Nuessler V, Schneider A, Adams M, Onon TS, Bauknecht T, Wagner U, Kroon K, Hickling J, Boswell CM, Stacey SN, Kitchener HC, Gillard J, Wanders J, Roberts JS, Zwierzina H. Clin Cancer Res; 2002 Dec 31; 8(12):3676-85. PubMed ID: 12473576 [Abstract] [Full Text] [Related]
33. E6 and E7 Gene Polymorphisms in Human Papillomavirus Types-58 and 33 Identified in Southwest China. Chen Z, Jing Y, Wen Q, Ding X, Wang T, Mu X, Chenzhang Y, Cao M. PLoS One; 2017 Dec 31; 12(1):e0171140. PubMed ID: 28141822 [Abstract] [Full Text] [Related]